Event & Product News

Gerresheimer further expanding production output in Asia

Celebrating the opening of the Changzhou plant in December 2019.

Düsseldorf/Paris, January 28, 2020 – Gerresheimer has over 35 sites in Europe, the Americas, and Asia making specialty packaging from glass and plastic. Not long ago, in December 2019, the company opened two more plants in China and India to manufacture plastic primary packaging for pharmaceutical products. This will enable it to offer its customers in this major region the best possible supply service.

“We have production facilities in North and South America, China, India, and Europe,” explains Niels Düring, Global Executive Vice President Plastic Packaging. “This puts us in an ideal position to look after our customers in all key parts of the world and provide them with pharmaceutical packaging made from plastic.” The new Chinese plant in the city of Changzhou was officially opened on December 11, 2019, with its Indian counterpart in Kosamba following suit five days later.

Leading brands for pharmaceutical packaging

As a specialist in plastic packaging for the pharmaceutical industry, Gerresheimer offers a wide range of packaging solutions for solid, liquid, and ophthalmological products. Our comprehensive and innovative product range includes the leading brands Duma, Dudek, and Triveni for solid dosage forms and the PET bottles for the brands EDP, Allplas, and Vedat for liquid dosage forms as well as products for ophthalmological applications. Our broad-based standard range encompasses all manner of different containers and closures, PET bottles, eye droppers, nasal sprays, and vaporizers as well as countless customizations.

The Kosamba plant is officially opened.
The Kosamba plant is officially opened.

High quality standards

The manufacturing process at all Gerresheimer Group plants complies with the same strict European and U.S. standards. With its zero-defect strategy, the company aims to ensure the highest possible quality at all plants in both its products and its processes. Gerresheimer is also developing sustainable concepts based on recycled plastic and BioPack, a plastic made of sugarcane.

GMP and cleanrooms

In its facilities in Europe, Asia, and the Americas, Gerresheimer produces plastic packaging in accordance with the GMP standard in class 7 and 8 cleanrooms as well as under less stringent controlled conditions. All plants are ISO-certified. A global database containing specifications for all
standard products facilitates a uniform manufacturing process for the company’s packaging, which is registered with the FDA and licensed in accordance with global regulations such as the U.S. and Canadian Drug Master Files (DMF) of the various pharmocopeias. The products are also registered for Russia, China, and Ukraine.

Gerresheimer operates at over 35 production sites across the globe and is continuously expanding them. The company recently opened two new plants in China and India for the production of plastic packaging to enable it to supply its customers with pharmace
Gerresheimer operates at over 35 production sites across the globe and is continuously expanding them. The company recently opened two new plants in China and India for the production of plastic packaging to enable it to supply its customers with pharmaceutical packaging in all key parts of the world.

At Pharmapack 2020 in Paris – Expo Porte de Versailles

Gerresheimer will be at Pharmapack on February 5 and 6, showcasing its sustainable and innovative packaging and administration solutions at booth B60/B64 in hall 7.2.

Gerresheimer’s production sites for plastic primary packaging:

Brazil
China
Denmark
India
Poland
Spain
U.S.
Plastic primary packaging for pharmaceuticals

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. Our comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Contact
Contact us!
Communication & Marketing
Mail
Press
Phone
+49 211 61 81 246
Mail